ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

CCOPs At Six Months: Sme Exceeding Patient Goals, Most Are Meeting Schedules

March 30, 1984

Beckman Coulter Offers Immunoassay System.

July 27, 2001

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

In Brief: Bailes Elected President Of ASCO For 1999; Outlines Goals In Remarks To ACCC

March 20, 1998

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

October 25, 1985